GIMAP5 and lymphopenia: However, reconstitution with Gimap5-sufficient cells greatly reduced the development of autoimmune diabetes in the rat model and the intestinal lesions in the mouse model [7,9], suggesting that the manifestation of the pathologies associated with the Gimap5 mutation are secondary to the lymphopenia-induced activation.